- ►ahajournals.org N Marx, H Duez, JC Fruchart, B Staels - Circulation Research, 2004 - Am Heart Assoc A large body of data gathered over the past couple of years has identified the
peroxisome proliferator-activated receptors (PPAR) , , and ß/ as transcription
factors exerting modulatory actions in vascular cells. PPARs, which belong ... Cited by 338 - Related articles - BL Direct - All 7 versions
X Zhang, P Shan, LE Otterbein, J Alam, RA … - Journal of Biological Chemistry, 2003 - ASBMB Carbon monoxide (CO), a reaction product of the cytoprotective gene heme
oxygenase, has been shown to be protective against organ injury in a variety of
models. One potential mechanism whereby CO affords cytoprotection is ... Cited by 146 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org E Aasum, AD Hafstad, DL Severson, TS … - Diabetes, 2003 - Am Diabetes Assoc Glucose and palmitate metabolism and contractile function were measured with ex
vivo perfused working hearts from control (db/+) and diabetic (db/db) female
mice at 6, 10–12, and 16–18 weeks of age. Palmitate oxidation was ... Cited by 102 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org JL Mehta, B Hu, J Chen, D Li - Arteriosclerosis, Thrombosis, and Vascular Biology, 2003 - Am Heart Assoc Methods and Results— Fourth generation HCAECs were treated with ox-LDL, Ang
II, or TNF- with or without pioglitazone pretreatment. All 3 stimuli upregulated
LOX-1 expression (mRNA and protein). Pioglitazone, in a ... Cited by 98 - Related articles - BL Direct - All 8 versions
- ►cardiovascres.org M Abdelrahman, A Sivarajah, C Thiemermann - Cardiovascular research, 2005 - cardiovascres.org Peroxisome proliferator-activated receptor- (PPAR- ) is a ligand-activated
transcription factor belonging to the nuclear hormone receptor superfamily.
PPAR- regulates gene expression by forming a heterodimer with the retinoid ... Cited by 92 - Related articles - All 6 versions
A Sivarajah, PK Chatterjee, NSA Patel, Z … - Am J Nephrol, 2003 - content.karger.com Background/Aims: Recent evidence indicates that peroxisome-proliferator
activated receptor (PPAR) agonists protect against ischemia/reperfusion (I/R)
injury. Here we investigate the effects of the PPAR- agonists, ... Cited by 90 - Related articles - BL Direct - All 6 versions
B Zingarelli, JA Cook - Shock, 2005 - journals.lww.com Received 31 Jan 2005; first review completed 9 Feb 2005; accepted in final form
15 Feb 2005 ABSTRACT—Peroxisome proliferator-activated receptor-g (PPARg) is a
member of the nuclear receptor superfamily and a ligand-activated ... Cited by 89 - Related articles - All 9 versions
CH Wang, RD Weisel, PP Liu, PWM Fedak, S … - Circulation, 2003 - Am Heart Assoc Mr S. is a 46-year-old East-Indian male with typical manifestations of the
cardiovascular dysmetabolic syndrome of insulin resistance (type II diabetes,
obesity, dyslipidemia, hypertension, and elevated levels of ... Cited by 90 - Related articles - BL Direct - All 6 versions
- ►pitt.edu [PDF] M Collino, M Aragno, R Mastrocola, M … - European journal of pharmacology, 2006 - Elsevier Agonists of the peroxisome proliferator-activated receptor-γ (PPAR-γ) exert
protective effects in several models of ischemia/reperfusion injury, but their
role in stroke is less clear. The study investigates the effects of two ... Cited by 78 - Related articles - All 5 versions
